Now Available: Spotlight on Stilla Technologies Remi Dangla, PhD – CEO. Click here to read.
Broken String Biosciences (“Broken String”), a genomics company building a technology platform to drive the development of cell and gene therapies that are safer by design, today announced that it has closed a $15 million Series A investment round, co-led by Illumina Ventures and Mérieux Equity Partners...
Lightcast Discovery Ltd. (“Lightcast” or the “Company”), a life science tools company developing a novel single-cell functional analysis platform, today announced the completion of a £38M (c. $49 million) Series B funding round, led by M Ventures.
DELFI Diagnostics is developing a new generation of liquid biopsies that could advance these applications. Built on a new method called fragmentomics and amplified by machine learning, DELFI’s approach is already showing promise, providing early detection for lung, liver and other cancers, and could provide essential insights to inform precision medicine.
Illumina Ventures, a leading genomics and precision health venture firm, today announced plans to launch Illumina® Ventures Labs.
Your screen does not meet the requirements for generating previews. Adjust your screen width to exactly 1920px before proceeding, otherwise you'll not be able to generate previews.
